Minsheng Health released its 2026 half-year report. Net profit attributable to the parent in the first half was 83.39 million yuan, up 1.2% year on year. Operating revenue was 535 million yuan, up 15.8% year on year. Net profit attributable to the parent after deducting non-recurring items was 86.23 million yuan, up 8.7% year on year. Net operating cash flow was 137 million yuan, down 3.7% year on year. Earnings per share were 0.2339 yuan. In the second quarter, operating revenue was 218 million yuan, up 14.1% year on year, and net profit attributable to the parent was 20.62 million yuan, up 4.6% year on year. As of the end of the second quarter, total assets were 2.104 billion yuan, up 4.3% from the end of the previous year, and net assets attributable to the parent were 1.612 billion yuan, up 0.9% from the end of the previous year. The company's main product, 21 Gold Vita multivitamin tablets, has performed well in the market, and the company is expanding its business through distributors and online channels.
Hangzhou Minsheng Healthcare Co LtdFirst-half net profit up 1.2% and revenue up 15.8%, with strong performance of main product.
